When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...

LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...

Detailed price information for Eyepoint Pharmaceuticals Inc (EYPT-Q) from The Globe and Mail including charting and trades.

Randomized control trials ... design, placebo manufacture, recruitment, and study execution, to sample and data analysis, statistics, and report/dossier preparation to provide a service that ...

Randomized controlled trials in oncology can make or break an investigational drug, with both patient lives and pharmaceutical company profits at stake. These trials typically pit two options ...

Although regulators have not typically required sponsors to include crossover in randomized trials, 4 optimal postprogression therapy is also essential to the scientific integrity and clinical value ...

In addition to clinical trial design, the findings of the current study are relevant for evaluating randomized controlled trials in SPMS, Koch and colleagues reported. “Over the last few years ...

A total of 101 children underwent randomization (78 to the closed-loop group and 23 to the control ... trial website with the use of a computer-generated sequence with a permuted block design ...